Latest Price Inquiry of Rasagiline in 2026

Rasagiline, a drug used to treat Parkinson's disease, has been marketed in many countries around the world and has been included in medical insurance in my country, making it easier for patients to obtain treatment. Regarding its price, it differs depending on the market, region and version, so the following is the latest price information.

In the Chinese market, rasagiline has been approved for marketing and included in the scope of medical insurance reimbursement. However, the specific medical insurance reimbursement prices will vary according to the policies of different regions, so patients need to consult local hospitals and pharmacies for specific prices and reimbursement policies when purchasing. Generally speaking, the price of rasagiline ranges from a few hundred yuan to more than a thousand yuan, which makes it relatively affordable, especially for patients with Parkinson's disease. It is an affordable treatment option.

In the Turkish market, the price of rasagiline’s original drug is approximately RMB 1,000 per box. Because this drug is an original drug, its price is relatively high, but its ingredients and efficacy are basically the same as rasagiline in the domestic market, so it is still the choice of many patients.

In addition, generic drugs of rasagiline are also on the market in countries such as India. The price of generic drugs is usually cheaper than the original drug. The price of the Indian version of rasagiline generic drug is about more than 300 yuan. Although the price of generic drugs is less than half of the original drugs, their drug ingredients are almost the same as the original drugs and can provide patients with similar therapeutic effects as the original drugs. Due to their price advantages, Indian generic drugs have become an affordable choice for many patients.

The price difference between rasagiline in domestic and overseas markets is mainly determined by factors such as market positioning, production costs and regional policies. Despite the price difference, rasagiline remains an important drug for the treatment of Parkinson's disease, especially for patients who require long-term treatment. Reasonable drug selection and price are crucial to its therapeutic effect.

Keyword tags: Rasagiline,Rasagiline, drug price, medical insurance reimbursement, Turkish original drug, Indian generic drug, Parkinson's disease, drug selection, price difference

Reference materials:https://go.drugbank.com/drugs/DB01367